Carcinoembryonic antigen (CEA) and CA19-9 have been commonly assessed in CRC patients, but with varying results depending on the study design and the study population [4], and their clinical association with cancer metastasis have not been demonstrated thus far. This evidence concerns the gene CEACAM5 and cancer.